Last reviewed · How we verify

Acetaminophen tablets

Maoxiang Group Jilin Pharmaceutical Co., Ltd. · FDA-approved active Small molecule

Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.

Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. Used for Mild to moderate pain, Fever reduction.

At a glance

Generic nameAcetaminophen tablets
SponsorMaoxiang Group Jilin Pharmaceutical Co., Ltd.
Drug classAnalgesic and antipyretic
TargetCyclooxygenase (COX), primarily in central nervous system
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Acetaminophen is believed to work primarily through inhibition of cyclooxygenase (COX) enzymes in the brain and spinal cord, reducing prostaglandin production and thereby lowering the pain threshold and resetting the hypothalamic thermoregulatory set point. Unlike NSAIDs, it has minimal peripheral anti-inflammatory effects and does not significantly inhibit COX in peripheral tissues.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: